Moriyama, E.; Shimose, S.; Niizeki, T.; Iwamoto, H.; Tanaka, M.; Shirono, T.; Noda, Y.; Nakano, M.; Kuromatsu, R.; Koga, H.;
et al. Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma. Curr. Oncol. 2024, 31, 5821-5831.
https://doi.org/10.3390/curroncol31100432
AMA Style
Moriyama E, Shimose S, Niizeki T, Iwamoto H, Tanaka M, Shirono T, Noda Y, Nakano M, Kuromatsu R, Koga H,
et al. Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma. Current Oncology. 2024; 31(10):5821-5831.
https://doi.org/10.3390/curroncol31100432
Chicago/Turabian Style
Moriyama, Etsuko, Shigeo Shimose, Takashi Niizeki, Hideki Iwamoto, Masatoshi Tanaka, Tomotake Shirono, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga,
and et al. 2024. "Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma" Current Oncology 31, no. 10: 5821-5831.
https://doi.org/10.3390/curroncol31100432
APA Style
Moriyama, E., Shimose, S., Niizeki, T., Iwamoto, H., Tanaka, M., Shirono, T., Noda, Y., Nakano, M., Kuromatsu, R., Koga, H., & Kawaguchi, T.
(2024). Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma. Current Oncology, 31(10), 5821-5831.
https://doi.org/10.3390/curroncol31100432
